Bruker’s ultrafleXtreme™ MALDI-TOF/TOF to be Coupled with Nextval’s MassInsight™ High-Throughput Pharmaceutical Assay...
16 October 2012 - 10:00PM
Business Wire
Bruker today announces a collaboration between Bruker and
Nextval for high-throughput screening of drugs and their
metabolites using Bruker’s ultrafleXtreme MALDI-TOF/TOF in
conjunction with Nextval’s MassInsight technology.
ultrafleXtreme MALDI-TOF/TOF system
(Photo: Business Wire)
The ultrafleXtreme mass spectrometer combines the
acquisition speed of its 2 kHz smartbeam IITM laser with its
Perpetual Ion Source for unrivalled productivity, ensuring optimum
performance for low concentration high-throughput screening. The
versatility of Bruker’s CompassTM software allows
integration with Nextval’s screening technology to maximize sample
density and reduce sample analysis costs.
Nextval’s MassInsight screening technology is based on
novel surface chemistries coupled with unique microarray acoustic
deposition methods (EDC Biosystems & BioSero LLC) that address
critical needs in several industries including the pharmaceutical,
testing and industrial markets.
Dr. Matthew Greving, CSO of Nextval, stated: “The ultrafleXtreme
is an invaluable tool for Nextval because it combines the
sensitivity and throughput needed for our MassInsight customers,
enabling fast accurate screening of potential drug candidates and
enzyme activity.” Nextval recently has been awarded a Phase II SBIR
grant to further develop and commercialize their MassInsight
technology for high-throughput enzyme assays.
Dr. Paul Speir, Senior Vice President of Bruker Daltonics
stated: “We are excited by the combination of Nextval’s MassInsight
technology with the information rich, high throughput capabilities
provided by the ultrafleXtreme. Moreover, we are pleased to support
Nextval in their efforts to develop this important technology for
the rapid and economical screening of drug candidates.”
About Bruker Corporation
Bruker Corporation (NASDAQ: BRKR) is a leading provider of
high-performance scientific instruments and solutions for molecular
and materials research, as well as for industrial and applied
analysis. For more information, please visit www.bruker.com.
Follow Us On:
About Nextval Corporation
Nextval, Inc. is a company developing next generation
high-throughput high-content mass based screening assays. For more
information please visit www.nextval.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50439924&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024